NIH Reform Act
This bill separates the National Institute of Allergy and Infectious Diseases (NIAID) into three separate institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
The bill also requires that the President appoint the directors of the new institutes (under current law, the Director of NIAID is appointed by the Director of the National Institutes of Health). It further requires that the Senate confirm the appointment of the directors of the new institutes and the National Cancer Institute.
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1768 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 1768
To replace the National Institute of Allergy and Infectious Diseases
with 3 separate national research institutes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 23, 2023
Mr. Roy (for himself, Mrs. Miller of Illinois, Mr. Gosar, Mr. Jackson
of Texas, Ms. Hageman, Mrs. Boebert, Mr. Biggs, Mr. Burlison, Mr.
Rosendale, Mr. Brecheen, Mrs. Luna, Mr. Bishop of North Carolina, Mr.
Gaetz, Mr. Steube, Mr. Gooden of Texas, and Mr. Good of Virginia)
introduced the following bill; which was referred to the Committee on
Energy and Commerce
_______________________________________________________________________
A BILL
To replace the National Institute of Allergy and Infectious Diseases
with 3 separate national research institutes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``NIH Reform Act''.
SEC. 2. DIVISION OF NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
DISEASES.
(a) Organization of National Research Institutes.--Section 401 of
the Public Health Service Act (42 U.S.C. 281) is amended--
(1) in subsection (b)--
(A) in paragraph (6), by striking ``Allergy and
Infectious Diseases'' and inserting ``Allergic
Diseases'';
(B) by redesignating paragraph (25) as paragraph
(27); and
(C) by inserting after paragraph (24) the
following:
``(25) The National Institute of Infectious Diseases.
``(26) The National Institute of Immunologic Diseases.'';
and
(2) in subsection (d)(1), by striking ``27'' and inserting
``29''.
(b) Appointment of Directors.--
(1) In general.--Section 405(a)(1) of the Public Health
Service Act (42 U.S.C. 284(a)(1)) is amended--
(A) by inserting ``, the Director of the National
Institute of Allergic Diseases, the Director of the
National Institute of Infectious Diseases, and the
Director of the National Institute of Immunologic
Diseases'' after ``National Cancer Institute''; and
(B) by inserting ``by and with the advice and
consent of the Senate,'' after ``the President,''.
(2) Terms.--Section 405(a) of the Public Health Service Act
(42 U.S.C. 284(a)) is amended by adding at the end the
following:
``(4) Certain appointments by the president.--The
appointments by the President of the Director of the National
Institute of Allergic Diseases, the Director of the National
Institute of Infectious Diseases, and the Director of the
National Institute of Immunologic Diseases shall be for terms
of 5 years. Each such Director may be reappointed for not more
than 1 additional term, in accordance paragraph (1).''.
(3) Transition.--Effective on the date of enactment of this
Act, the position of Director of the National Institute of
Allergy and Infectious Diseases is terminated, and the National
Institute of Allergic Diseases, the National Institute of
Infectious Diseases, and the National Institute of Immunologic
Diseases shall be overseen by the Director of the National
Institutes of Health until such time as the directors of each
such national institutes is appointed pursuant to section
405(a)(1) of the Public Health Service Act (42 U.S.C.
284(a)(1)), as amended by paragraph (1).
(c) Duties of the National Institutes.--
(1) National institute of allergic diseases.--Subpart 6 of
part C of title IV of the Public Health Service Act (42 U.S.C.
285f et seq.) is amended--
(A) in the subpart heading, by striking ``Allergy
and Infectious Diseases'' and inserting ``Allergic
Diseases''; and
(B) in section 446--
(i) by striking ``Allergy and Infectious
Diseases'' and inserting ``Allergic Diseases'';
and
(ii) by striking ``allergic and immunologic
diseases and disorders and infectious diseases,
including tropical diseases'' and inserting
``allergic diseases and disorders''.
(2) National institute of infectious diseases.--
(A) In general.--Part C of title IV of the Public
Health Service Act (42 U.S.C. 285 et seq.) is amended
by adding at the end the following:
``Subpart 21--National Institute of Infectious Diseases
``SEC. 464Z-10. PURPOSE OF THE INSTITUTE.
``The general purpose of the National Institute of Infectious
Diseases is the conduct and support of research, training, health
information dissemination, and other programs with respect to
infectious diseases, including tropical diseases.''.
(B) Transfer of authorities.--Sections 447A and
447B of the Public Health Service Act (42 U.S.C. 285f-
2; 285f-3) are--
(i) redesignated as sections 464z-11 and
464-12, respectively; and
(ii) transferred to appear after section
464z-10 of such Act, as added by subparagraph
(A).
(C) Orderly transition.--The Director of the
National Institutes of Health shall take such steps as
are necessary to provide for the orderly transition to
the authority of the National Institute of Infectious
Diseases established under section 464z-10 of the
Public Health Service Act, as added by subparagraph
(A), from any authority related to infectious diseases
of the National Institute of Allergy and Infectious
Diseases, as in effect on the day before the date of
enactment of this Act.
(3) National institute of immunologic diseases.--
(A) In general.--Part C of title IV of the Public
Health Service Act (42 U.S.C. 285 et seq.), as amended
by paragraph (2), is further amended by adding at the
end the following:
``Subpart 22--National Institute of Immunologic Diseases
``SEC. 464Z-15. PURPOSE OF THE INSTITUTE.
``The general purpose of the National Institute of Immunologic
Diseases is the conduct and support of research, training, health
information dissemination, and other programs with respect to
immunologic diseases and disorders.''.
(B) Transfer of authorities.--Sections 447 and 447C
of the Public Health Service Act (42 U.S.C. 285f-1;
285f-4) are--
(i) redesignated as sections 464z-16 and
464z-17, respectively; and
(ii) transferred to appear after section
464z-15 of such Act, as added by subparagraph
(A).
(C) Orderly transition.--The Director of the
National Institutes of Health shall take such steps as
are necessary to provide for the orderly transition to
the authority of the National Institute of Immunologic
Diseases established under section 464z-15 of the
Public Health Service Act, as added by subparagraph
(A), from any authority related to immunologic diseases
and disorders of the National Institute of Allergy and
Infectious Diseases, as in effect on the day before the
date of enactment of this Act.
(d) Conforming Amendments.--
(1) Section 404B of the Public Health Service Act (42
U.S.C. 283d) is amended by striking ``National Institute for
Allergy and Infectious Diseases'' and inserting ``National
Institute for Infectious Diseases''.
(2) Section 404I of the Public Health Service Act (42
U.S.C. 283k) is amended--
(A) in subsection (a)(1), by striking ``or the
Director of the National Institute for Allergy and
Infectious Diseases''; and
(B by striking ``or the National Institute for
Allergy and Infectious Diseases'' each place it
appears.
(3) Section 442A(a) of the Public Health Service Act (42
U.S.C. 285d-8(a)) is amended by striking ``Allergy and
Infectious Diseases'' and inserting ``Immunologic Diseases''.
(4) Any reference in any law (including a regulation),
guidance, map, document, record, or other paper of the United
States to the National Institute of Allergy and Infectious
Diseases, including with respect to the Director of such
Institute, shall be deemed to be a reference to, as applicable,
the National Institute of Allergic Diseases, the National
Institute of Infectious Diseases, or the National Institute of
Immunologic Diseases, including with respect to the Directors
of such Institutes.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line